BRYAN FARTHING: Open Payments
NPI 1003245788 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$48,860 in 202 payments from 23 companies in 2025. Trend: 2023 $21,558 · 2024 $43,823 · 2025 $48,860
Speaker / faculty: $33,107Travel & lodging: $8,054Food & beverage: $4,836Consulting: $2,734Education: $129
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 76 | $28,142 |
| Regeneron Healthcare Solutions, Inc. | 15 | $8,036 |
| GENZYME CORPORATION | 26 | $5,855 |
| Genentech USA, Inc. | 8 | $3,346 |
| Novartis Pharmaceuticals Corporation | 7 | $1,876 |
| GlaxoSmithKline, LLC. | 27 | $376 |
| BioCryst US Sales Co., LLC | 7 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $159 |
| CSL Behring | 9 | $146 |
| Genentech, Inc. | 1 | $135 |
Products named: AIRSUPRA, DUPIXENT, TEZSPIRE, Xolair, FASENRA, NUCALA, ORLADEYO, WAYRILZ.
Industry payments across AK — which companies pay providers there.
